Skip to content

The Effects of Water-only Fasting and Refeeding on Body Composition

A Pilot Study on the Effects of Water-only Fasting and Refeeding on Body Composition and Insulin Resistance

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04514146
Enrollment
48
Registered
2020-08-14
Start date
2020-08-15
Completion date
2021-10-01
Last updated
2021-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visceral Obesity, Insulin Resistance

Keywords

water-only fasting, HOMA-IR, insulin resistance, visceral adipose tissue

Brief summary

This observational pilot study will assess the effects of water-only fasting on body composition and insulin resistance

Detailed description

This pilot study will explore the effects of water-only fasting followed by an exclusively whole-plant-food diet free of added salt, oil, and sugar on body composition with a particular focus on visceral adipose tissue (VAT). The study will also extend a previous study assessing the effects of fasting and refeeding on Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) values and markers of cardiovascular health and inflammation by following participants for an additional 6 weeks.

Interventions

In-patient water-only fasting for at least 10 days followed by at least 5 days of refeeding

Sponsors

TrueNorth Health Foundation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years

Inclusion criteria

* Any gender * 40-70 years old * Fasting plasma glucose \<126mg/dL and/or hemoglobin A1c \<7% * BMI between 25 and 40 kg/m2 * Elect and qualify for a water-only fast of at least 10 consecutive days * Provide informed consent * Internet and computer access * Able to return for 6-week follow-up visit

Exclusion criteria

* Active malignancy * Active inflammatory disorder including classic autoimmune connective tissue (Lupus, Sjogrens, ANCA), multiple sclerosis, and inflammatory bowel disorders (Ulcerative colitis, Crohn's) * Stroke or heart attack within the last 12 months * Break water-only fast before 10 days with juice or food. * Break water-only fast after 10 days with juice or food before end-of-fast blood draw occurs. * Leave center before completing at least 5 days of refeeding * Unable to lay still on the back for at least 10 min * Abdominal metal implants

Design outcomes

Primary

MeasureTime frameDescription
Mean changes in visceral adipose tissue from baselineBaseline, up to 10 to 40 days after baseline, up to 5 to 20 days after end of fast, 6-weeks after end of refeedVisceral adipose tissue will be estimated using Holigic Horizon dual-energy X-ray absorptiometry (DXA) machine and reported in grams

Secondary

MeasureTime frameDescription
Mean changes in total fat and lean mass and bone mineral content (BMC) from baselineBaseline, up to 10 to 40 days after baseline, up to 5 to 20 days after end of fast, 6-weeks after end of refeedTotal fat and lean mass and BMC will be estimated using Holigic Horizon dual-energy X-ray absorptiometry (DXA) machine and reported in grams

Other

MeasureTime frameDescription
Mean changes in insulin resistance from baselineBaseline, up to 10 to 40 days after baseline, up to 5 to 20 days after end of fast, 6-weeks after end of refeedInsulin resistance will be assessed using serum glucose and insulin to calculate homeostatic model of insulin resistance (HOMA-IR) \[fasting insulin (microU/L) x fasting glucose (nmol/L)/22.5\]
Mean changes in abdominal circumference from baselineBaseline, up to 10 to 40 days after baseline, up to 5 to 20 days after end of fast, 6-weeks after end of refeedAbdominal circumference will be measured on bare skin at the minimal waistline with a tension-sensitive, non-elastic tape and reported in centimeters (cm)
Mean changes in lipid profile from baselineBaseline, up to 10 to 40 days after baseline, up to 5 to 20 days after end of fast, 6-weeks after end of refeedLipid profile will be assessed using serum to measure cholesterol, triglycerides, high-density lipoprotein (HDL), and lowdensity lipoprotein (LDL) and reported in mg/dL
Mean changes in Gamma-Glutamyl-Transferase (GGT) from baselineBaseline, up to 10 to 40 days after baseline, up to 5 to 20 days after end of fast, 6-weeks after end of refeedGGT will assessed using serum and reported in U/L
Mean changes in high sensitivity C-reactive protein (hs-CRP) from baselineBaseline, up to 10 to 40 days after baseline, up to 5 to 20 days after end of fast, 6-weeks after end of refeedhsCRP will assessed using serum and reported in mg/L
Mean changes in weight from baselineBaseline, up to 10 to 40 days after baseline, up to 5 to 20 days after end of fast, 6-weeks after end of refeedWeight will be measured on a digital scale and reported in kilograms (kg)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026